Cargando…

Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy

BACKGROUND: Replication-competent oncolytic viruses (OVs) have been proven to be a potent anticancer weapon for clinical therapy. The preexisting neutralizing antibody in patients is a big challenge for oncolytic efficacy of OVs. Graphene oxide sheets (GOS) possess excellent biological compatibility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Mao, Luo, Dongjun, Dong, Jie, Zheng, Meihong, Meng, Gang, Wu, Junhua, Wei, Jiwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749703/ https://www.ncbi.nlm.nih.gov/pubmed/31533779 http://dx.doi.org/10.1186/s13046-019-1410-x

Ejemplares similares

Oncolytic measles virus enhances antitumour responses of adoptive CD8(+)NKG2D(+) cells in hepatocellular carcinoma treatment
por: Chen, Aiping, et al.
Publicado: (2017)

Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus
por: Xia, Mao, et al.
Publicado: (2014)

Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
por: Xu, Chun, et al.
Publicado: (2018)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Measles to the Rescue: A Review of Oncolytic Measles Virus
por: Aref, Sarah, et al.
Publicado: (2016)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Advances in the design and development of oncolytic measles viruses
por: Hutzen, Brian, et al.
Publicado: (2015)

Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
por: Meng, Gang, et al.
Publicado: (2019)

Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
por: Meng, Gang, et al.
Publicado: (2014)

Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020)

Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor
por: Zhang, Yonghui, et al.
Publicado: (2020)

Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma
por: Li, Chunyan, et al.
Publicado: (2014)

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
por: Kemler, Iris, et al.
Publicado: (2018)

Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
por: Scheubeck, Gabriel, et al.
Publicado: (2019)

A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
por: Loewe, Daniel, et al.
Publicado: (2022)

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
por: Singh, Hans Martin, et al.
Publicado: (2021)

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †
por: Anker, Sophie C., et al.
Publicado: (2023)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
por: Nagalo, Bolni Marius, et al.
Publicado: (2020)

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H.pylori immunostimulatory bacterial transgene
por: Viker, Kimberly B., et al.
Publicado: (2022)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells
por: Wang, Diancheng, et al.
Publicado: (2016)

Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death
por: Lal, Geetanjali, et al.
Publicado: (2019)

Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
por: Leber, Mathias Felix, et al.
Publicado: (2018)

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2017)

Aeration and Shear Stress Are Critical Process Parameters for the Production of Oncolytic Measles Virus
por: Grein, Tanja A., et al.
Publicado: (2019)

Cowpox Virus: A New and Armed Oncolytic Poxvirus
por: Ricordel, Marine, et al.
Publicado: (2017)

MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum
por: Muñoz-Alía, Miguel Ángel, et al.
Publicado: (2021)

Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins
por: Hudacek, Andrew W., et al.
Publicado: (2013)

Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus
por: Lal, Sangeet, et al.
Publicado: (2017)

Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance
por: Zhang, Hailin, et al.
Publicado: (2020)

Suicide gene-armed measles vaccine virus for the treatment of AML
por: Maurer, Stefanie, et al.
Publicado: (2019)

Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
por: Boisgerault, Nicolas, et al.
Publicado: (2013)

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
por: Allen, Cory, et al.
Publicado: (2012)

Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells
por: Liu, Ching-Hsuan, et al.
Publicado: (2023)

Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma
por: Zhang, Shu-Cheng, et al.
Publicado: (2012)

Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT)
por: Zuo, Shuguang, et al.
Publicado: (2021)

Armed oncolytic viruses: A kick-start for anti-tumor immunity
por: de Graaf, J.F., et al.
Publicado: (2018)

Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity
por: Xie, Jun, et al.
Publicado: (2023)

An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade
por: Zuo, Shuguang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_114oqbpkl3in3jhpmj8rillk2g